Tag Archives: Roth Capital

VirTra (VTSI) Receives a Buy from Roth Capital

Roth Capital analyst Roth Capital maintained a Buy rating on VirTra (VTSI – Research Report) yesterday and set a price target of $10.00. The company’s shares closed last Tuesday at $5.33. The word on The Street in general, suggests a

Roth Capital Reiterates Buy on CohBar Shares, Sees 742% Upside For The Stock

In a research report sent to investors on Monday, Roth Capital analyst Elemer Piros reiterated a Buy rating on CohBar (NASDAQ:CWBR)with a price target of $8, which implies an upside of 742% from current levels. According to TipRanks.com, which measures

Roth Capital Reiterates a Buy Rating on Seelos Therapeutics (SEEL)

In a report issued on September 9, Jonathan Aschoff from Roth Capital reiterated a Buy rating on Seelos Therapeutics (NASDAQ: SEEL), with a price target of $12.00. The company’s shares closed last Monday at $0.78. Currently, the analyst consensus on

Roth Capital Reaffirms Their Buy Rating on Seelos Therapeutics (SEEL)

In a report issued on September 9, Jonathan Aschoff from Roth Capital reiterated a Buy rating on Seelos Therapeutics (NASDAQ: SEEL), with a price target of $12.00. The company’s shares closed last Monday at $0.78. Seelos Therapeutics has an analyst

Digi International (DGII) Gets a Buy Rating from Roth Capital

In a report issued on August 7, Scott Searle from Roth Capital reiterated a Buy rating on Digi International (NASDAQ: DGII), with a price target of $20.00. The company’s shares closed last Friday at $13.45. Currently, the analyst consensus on

Roth Capital Reiterates Buy on Allena Pharmaceuticals Shares, Sees 675% Upside For The Stock

In a research report released on Thursday, Roth Capital analyst Yasmeen Rahimi reiterated a Buy rating on Allena Pharmaceuticals (NASDAQ:ALNA)with a price target of $11, which implies an upside of 675% from current levels. According to TipRanks.com, which measures analysts’